Skip to main content

Table 1 Comorbidities associated with neuromuscular diseases

From: Experience in neuromuscular diseases in children and adolescents and their comorbidities in a tertiary hospital

 

Group I. (n = 15)

Group II. (n = 40)

Group III (n = 41)

P

Scoliosis

10 (66.7%) a,b

11 (27.5%)

14 (34.1%)

0.025

Rib cage deformities

4 (26.7%) a,b

0

0

< 0.001

Myocardiopathy

2 (13.3) a,b

0

2 (4.9%)

0.064

Deglutition disorders y/o GERD

5 (33.3%) a,b

4 (10%)

5 (12.2%)

0.119

Lung infection

8 (53.3%) a,b

8 (20%)

3 (7.3%)

0.001

Bronchial aspiration

2 (13.3%)

4 (10%)

0

0.023

SAHS /Nocturnal hypoventilation

3 (20%)

1 (2.5%)

2 (4.9%)

0.114

Chronic respiratory insufficiency

9 (60%) a,b

4 (10%)

4 (9.8%)

0.001

  1. Group I Involvement of the motor neuron; Group II: Peripheral neuropathies; Group III: Myopathies. SAHS Sleep apnea-hypopnea síndrome, GERD Gastroesophageal reflux disease - a: p < 0.05 between group I and group II; b: p < 0.05 between group I and group III